McGahan Keith M 4
4 · SPECTRUM PHARMACEUTICALS INC · Filed Jun 23, 2022
Insider Transaction Report
Form 4
McGahan Keith M
SVP and Chief Legal Officer
Transactions
- Award
Common Stock, $0.001 par value
2022-06-21+246,085→ 491,025 total - Award
Stock Option (Right to Buy)
2022-06-21+904,077→ 904,077 totalExercise: $0.63Exp: 2032-01-27→ Common Stock (904,077 underlying)
Holdings
- 6,250(indirect: By 401(k))
Common Stock, $0.001 par value
Footnotes (3)
- [F1]The restricted stock unit grant was approved by Spectrum Pharmaceuticals, Inc.'s ("Spectrum") board of directors on January 27, 2022, subject to stockholder approval of the Amended and Restated 2018 Long-Term Incentive Plan (the "Plan") under which the restricted stock unit was granted. Spectrum's stockholders approved the Plan on June 21, 2022.
- [F2]The option grant was approved by Spectrum's board of directors on January 27, 2022, subject to stockholder approval of the Plan under which the option was granted. Spectrum's stockholders approved the Plan on June 21, 2022.
- [F3]One third of the aggregate amount of option shares shall vest on each of January 27, 2023, 2024 and 2025, respectively.